These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9747820)

  • 1. Adjuvant therapy for pancreatic cancer: back to the future.
    Regine WF; Abrams RA
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):59-63. PubMed ID: 9747820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after chemoradiation in resected pancreatic cancer: the impact of adjuvant gemcitabine.
    Baschnagel A; Shah C; Margolis J; Nadeau L; Stein J; Jury R; Robertson JM
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e331-5. PubMed ID: 22420967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma.
    Lin LL; Picus J; Drebin JA; Linehan DC; Solis J; Strasberg SM; Tan B; Thorstad WL; Myerson R
    Am J Clin Oncol; 2005 Jun; 28(3):234-41. PubMed ID: 15923794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
    Crane CH; Abbruzzese JL; Evans DB; Wolff RA; Ballo MT; Delclos M; Milas L; Mason K; Charnsangavej C; Pisters PW; Lee JE; Lenzi R; Vauthey JN; Wong AB; Phan T; Nguyen Q; Janjan NA
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1293-302. PubMed ID: 11955742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined-modality therapy in pancreatic cancer: current status and future directions.
    McGinn CJ; Zalupski MM
    Cancer J; 2001; 7(4):338-48. PubMed ID: 11561609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine.
    Allen AM; Zalupski MM; Robertson JM; Eckhauser FE; Simone D; Brown D; Hejna G; Normolle D; Lawrence TS; McGinn CJ
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1461-7. PubMed ID: 15275733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy in pancreatic cancer: a critical appraisal.
    Oettle H; Neuhaus P
    Drugs; 2007; 67(16):2293-310. PubMed ID: 17983252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study.
    Van Laethem JL; Demols A; Gay F; Closon MT; Collette M; Polus M; Houbiers G; Gastelblum P; Gelin M; Houtte PV; Closset J
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):974-80. PubMed ID: 12829132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreas.
    Kachnic LA; Shaw JE; Manning MA; Lauve AD; Neifeld JP
    Int J Cancer; 2001 Apr; 96(2):132-9. PubMed ID: 11291097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.
    Regine WF; Winter KA; Abrams R; Safran H; Hoffman JP; Konski A; Benson AB; Macdonald JS; Rich TA; Willett CG
    Ann Surg Oncol; 2011 May; 18(5):1319-26. PubMed ID: 21499862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.
    Abrams RA; Grochow LB; Chakravarthy A; Sohn TA; Zahurak ML; Haulk TL; Ord S; Hruban RH; Lillemoe KD; Pitt HA; Cameron JL; Yeo CJ
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1039-46. PubMed ID: 10421536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer.
    Epelbaum R; Rosenblatt E; Nasrallah S; Faraggi D; Gaitini D; Mizrahi S; Kuten A
    J Surg Oncol; 2002 Nov; 81(3):138-43. PubMed ID: 12407726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.
    Abrams RA; Winter KA; Regine WF; Safran H; Hoffman JP; Lustig R; Konski AA; Benson AB; Macdonald JS; Rich TA; Willett CG
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):809-16. PubMed ID: 21277694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II study.
    Brade A; Brierley J; Oza A; Gallinger S; Cummings B; Maclean M; Pond GR; Hedley D; Wong S; Townsley C; Brezden-Masley C; Moore M
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1027-36. PubMed ID: 17197132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant Gemcitabine and Gemcitabine-based Chemoradiotherapy Versus Gemcitabine Alone After Pancreatic Cancer Resection: The Indiana University Experience.
    Khawaja MR; Kleyman S; Yu Z; Howard T; Burns M; Nakeeb A; Loehrer PJ; Cardenes HR; Chiorean EG
    Am J Clin Oncol; 2017 Feb; 40(1):42-46. PubMed ID: 25121637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of gemcitabine hydrochloride in the treatment for pancreatic cancer].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1461-7. PubMed ID: 11681259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiochemotherapy with gemcitabine and cisplatin in pancreatic cancer -- feasible and effective].
    Wilkowski R; Thoma M; Heinemann V; Rau HG; Wagner A; Stoffregen C; Dühmke E
    Strahlenther Onkol; 2003 Feb; 179(2):78-86. PubMed ID: 12590317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radically resected pancreatic cancer and adjuvant treatment. A review of the literature].
    Drudi F; Tassinari D; Giuliani J; Ridolfi C; Gianni L; Tamburini E; Fantini M; Santelmo C; Barzotti E; Lotti N; Ravaioli A
    Recenti Prog Med; 2013 Feb; 104(2):80-5. PubMed ID: 23535964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoradiation for ductal pancreatic carcinoma: principles of combining chemotherapy with radiation, definition of target volume and radiation dose.
    Wilkowski R; Thoma M; Weingandt H; Dühmke E; Heinemann V
    JOP; 2005 May; 6(3):216-30. PubMed ID: 15883472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Locoregional Failure and Impact on Overall Survival in Patients With Resected Exocrine Pancreatic Cancer.
    Merrell KW; Haddock MG; Quevedo JF; Harmsen WS; Kendrick ML; Miller RC; Hallemeier CL
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):561-70. PubMed ID: 26867884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.